Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum

Katrine R Schoennemann, Jon K Bjerregaard, Tine Hansen, Karin de Stricker, Morten F Gjerstorff, Helle A Jensen, Lene W Vestermark, Per Pfeiffer

18 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Biweekly cetuximab and irinotecan as second-line therapy in patients with gastro-esophageal cancer previously treated with platinum'. Together they form a unique fingerprint.

Medicine & Life Sciences